Refractory Focal Epilepsy
NO LONGER ACCEPTING APPLICATIONS
Published on:
September 18, 2024
Sign-up Expiration:
Updated:
Locations:
Charlotte, NC
Dr. Robert Nahouraii
A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of BHV-7000 in Subjects with Refractory Focal Epilepsy.
ENDED